These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 19089837)
1. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. Veiseh O; Gunn JW; Kievit FM; Sun C; Fang C; Lee JS; Zhang M Small; 2009 Feb; 5(2):256-64. PubMed ID: 19089837 [TBL] [Abstract][Full Text] [Related]
2. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. Veiseh O; Kievit FM; Fang C; Mu N; Jana S; Leung MC; Mok H; Ellenbogen RG; Park JO; Zhang M Biomaterials; 2010 Nov; 31(31):8032-42. PubMed ID: 20673683 [TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles. Sun C; Fang C; Stephen Z; Veiseh O; Hansen S; Lee D; Ellenbogen RG; Olson J; Zhang M Nanomedicine (Lond); 2008 Aug; 3(4):495-505. PubMed ID: 18694312 [TBL] [Abstract][Full Text] [Related]
4. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. Kievit FM; Veiseh O; Fang C; Bhattarai N; Lee D; Ellenbogen RG; Zhang M ACS Nano; 2010 Aug; 4(8):4587-94. PubMed ID: 20731441 [TBL] [Abstract][Full Text] [Related]
5. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Sun C; Veiseh O; Gunn J; Fang C; Hansen S; Lee D; Sze R; Ellenbogen RG; Olson J; Zhang M Small; 2008 Mar; 4(3):372-9. PubMed ID: 18232053 [TBL] [Abstract][Full Text] [Related]
6. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
8. Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs. Fu Y; An N; Li K; Zheng Y; Liang A J Neurooncol; 2012 May; 107(3):457-62. PubMed ID: 22108716 [TBL] [Abstract][Full Text] [Related]
9. Towards prostate cancer gene therapy: Development of a chlorotoxin-targeted nanovector for toxic (melittin) gene delivery. Tarokh Z; Naderi-Manesh H; Nazari M Eur J Pharm Sci; 2017 Mar; 99():209-218. PubMed ID: 28024889 [TBL] [Abstract][Full Text] [Related]
10. The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3. Qin C; He B; Dai W; Lin Z; Zhang H; Wang X; Wang J; Zhang X; Wang G; Yin L; Zhang Q Biomaterials; 2014 Jul; 35(22):5908-20. PubMed ID: 24743031 [TBL] [Abstract][Full Text] [Related]
11. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma. Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323 [TBL] [Abstract][Full Text] [Related]
12. Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy. Mu Q; Jeon M; Hsiao MH; Patton VK; Wang K; Press OW; Zhang M Adv Healthc Mater; 2015 Jun; 4(8):1236-45. PubMed ID: 25761648 [TBL] [Abstract][Full Text] [Related]
13. Development of the research on the application of chlorotoxin in imaging diagnostics and targeted therapies for tumors. Wu XS; Jian XC; Yin B; He ZJ Chin J Cancer; 2010 Jun; 29(6):626-30. PubMed ID: 20507737 [TBL] [Abstract][Full Text] [Related]
14. Deciphering the internalization mechanism of WRAP:siRNA nanoparticles. Deshayes S; Konate K; Dussot M; Chavey B; Vaissière A; Van TNN; Aldrian G; Padari K; Pooga M; Vivès E; Boisguérin P Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183252. PubMed ID: 32135145 [TBL] [Abstract][Full Text] [Related]
15. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. Mok H; Veiseh O; Fang C; Kievit FM; Wang FY; Park JO; Zhang M Mol Pharm; 2010 Dec; 7(6):1930-9. PubMed ID: 20722417 [TBL] [Abstract][Full Text] [Related]
16. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Veiseh M; Gabikian P; Bahrami SB; Veiseh O; Zhang M; Hackman RC; Ravanpay AC; Stroud MR; Kusuma Y; Hansen SJ; Kwok D; Munoz NM; Sze RW; Grady WM; Greenberg NM; Ellenbogen RG; Olson JM Cancer Res; 2007 Jul; 67(14):6882-8. PubMed ID: 17638899 [TBL] [Abstract][Full Text] [Related]
17. Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic cancer cells. El-Ghlban S; Kasai T; Shigehiro T; Yin HX; Sekhar S; Ida M; Sanchez A; Mizutani A; Kudoh T; Murakami H; Seno M Biomed Res Int; 2014; 2014():152659. PubMed ID: 24511528 [TBL] [Abstract][Full Text] [Related]
18. Fluorescent magnetic nanoparticles with specific targeting functions for combinded targeting, optical imaging and magnetic resonance imaging. Chen YC; Chang WH; Wang SJ; Hsieh WY J Biomater Sci Polym Ed; 2012; 23(15):1903-22. PubMed ID: 22024467 [TBL] [Abstract][Full Text] [Related]
19. Functionalized magnetic nanochains with enhanced MR imaging: A novel nanosystem for targeting and inhibition of early glioma. Zhang Y; Huang Z; Wu Z; Yin G; Wang L; Gao F Colloids Surf B Biointerfaces; 2016 Apr; 140():437-445. PubMed ID: 26803007 [TBL] [Abstract][Full Text] [Related]
20. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging. Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]